Many of the functional implications for ERs in modulating cardiometabolic risk have been discovered in rodents, where female mice with ESR1 mutations develop age-dependent vascular dysfunction and metabolic syndrome traits such as obesity, glucose intolerance, and insulin resistance [154,155]. This evidence concerns the gene ESR1 and Glucose intolerance.